SCHEMBL2583636

SCHEMBL2583636

c1ccc2nc(C3CNCC[N]3)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.42
KDM4E B2RXH2 5/20 0.42
CYP1A2 P05177 5/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP2D6 P10635 3/20 0.42
ALOX15 P16050 2/20 0.42
NISCH Q9Y2I1 1/20 0.42
PMP22 Q01453 2/20 0.41
LMNA P02545 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TP53 P04637 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 3/20 0.40
SLC6A4 P31645 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200705 0.76 HTR3A (0.33) CYP3A4KDM4ECYP1A2ALDH1A1CYP2D6
SCHEMBL5106520 0.74 NPC1 (0.42) CYP3A4KDM4ECYP1A2ALDH1A1CYP2D6
SCHEMBL9733257 0.73 CYP3A4 (0.41) CYP3A4KDM4ECYP1A2ALDH1A1CYP2D6
SCHEMBL1740642 0.73 ALDH1A1 (0.47) CYP3A4KDM4ECYP1A2ALDH1A1CYP2D6
SCHEMBL2203576 0.73 MEN1 (0.56) CYP3A4CYP1A2ALDH1A1ALOX15LMNA
SCHEMBL844622 0.72 NISCH (0.39) KDM4ECYP1A2ALDH1A1NISCHLMNA
Hydrochloric Acid SCHEMBL2596035 0.71 ALDH1A1 (0.46) CYP3A4KDM4ECYP1A2ALDH1A1CYP2D6
SCHEMBL4354860 0.71 DRD2 (0.46) CYP3A4CYP2D6
SCHEMBL27902231 0.71 DRD2 (0.46) CYP3A4CYP2D6
SCHEMBL571789 0.71 SLC18A3 (0.41) CYP3A4KDM4EALDH1A1NISCHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9085557-B2 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-07-21 US claimed
EP-2566863-B1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2014-05-14 EP claimed
US-20130190489-A1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-07-25 US claimed
EP-2566863-A1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF Council of Scientific and Industrial Research (IN) 2013-03-13 EP claimed
WO-2011138666-A1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2011-11-10 WO claimed
US-6043247-A A SUBSTITUTED ACRYLIC ACIDS FOR USE IN TREATMENT OF HUMAN AND ANIMAL DISORDERS, AND PURIFICATION OF PROTEINS OR GLYCOPROTEINS, AND TO THEIR USE IN DIAGNOSIS NOVO NORDISK A/S (DK) 2000-03-28 US claimed
US-9085557-B2 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-07-21 US disclosed
US-9085557-B2 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-07-21 US disclosed
EP-2566863-B1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2014-05-14 EP disclosed
US-20130190489-A1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-07-25 US disclosed
EP-2566863-A1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF Council of Scientific and Industrial Research (IN) 2013-03-13 EP disclosed
WO-2011138666-A1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2011-11-10 WO disclosed
US-7834015-B2 treatment of cancer, inflammatory diseases, reperfusion injuries, ischaemic conditions, stroke, renal failure, cardiovascular diseases, neurodegenerative diseases, retroviral infections, retinal damage, skin senescence and UV skin damage, and as chemosensitizers or radiosensitizers for cancer treatment INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-11-16 US disclosed
US-20090209523-A1 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190489-A1 QUINOLYLPIPERAZINO SUBSTITUTED THIOLACTONE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF SQOR, TST, FDPS CYP3A4 176/4885KDM4E 2108/4885CYP1A2 412/4885
US-20090209523-A1 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) PARP1, PARP2, PARP11 CYP3A4 2868/4885KDM4E 3630/4885CYP1A2 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.